Levonorgestrel-releasing intrauterine device (Mirena) now PBS listed for idiopathic menorrhagiaLevonorgestrel-releasing intrauterine device (Mirena) now PBS listed for idiopathic menorrhagia

Published 2007-08-01 00:00:00

The restricted PBS listing for levonorgestrel-releasing intrauterine device (Mirena) was extended on 1 August 2007 to include women in whom oral therapies for idiopathic menorrhagia are ineffective or contraindicated.1 This device was previously restricted for contraceptive use only.

The PBAC recommended extending the listing based on cost-minimisation compared with hysterectomy. Treatment with a levonorgestrel-releasing intrauterine device may not be a lasting alternative to hysterectomy for menorrhagia.2 However, it offers women a more conservative option that will allow them to become pregnant on removal of the device.

References

  1. Australian Government Department of Health and Ageing PBB. March 2007 PBAC Outcomes — Positive Recommendations. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/pbacrec-mar07-positive#lev (accessed 18 May 2007).
  2. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up. JAMA 2004;291:1456-63.
RSS FeedRSS feed

Date published: 2007-08-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.